Rochester,NY 8/7/2009 9:09:33 PM
Sequenom, Inc.SQNM faces loss on 2Q Due to Cost Rise,Sales Fall
Sequenom, Inc.
Sequenom Inc. The Diagnostic test maker faced a larger second-quarter loss on Thursday, Due to the economy loss sales of its MassArray platform, the company's legal and research costs increased.
http://StockEinstein.com offers free daily stock alerts on companies ready to run. Scroll to the bottom of this page to signup for free stock alerts and visit our site.
Sequenom reported that it lost $20.2 million, or 33 cents per share, compared with $9.7 million, or 21 cents per share, one year ago. The revenue of the company fell by 29 percent, to $9.2 million from $12.8 million.In aftermarket trading, Sequenom shares loss 74 cents, or 12.2 percent, to $5.34. The stock closed earlier at $6.08.
Sequenom said that it spent $10.2 million in research and development and $8.2 million in general and administrative spending, compared with $6.4 million and $4.3 million one year ago. The final quarter also included $1 million in restructuring costs.it said that the research costs has been increased, and it also purchased a clinical laboratory in November. It said that it has greater legal expenses and costs to hire a sales force for its products.Sequenom tightened its guidance for the year, saying it expects to lose about $65 million. Previously it expected a deficit of $62 million to $65 million.
StockEinstein.com has a dedicated team uncovering stocks ready to break and run. We apply time tested criteria and when one of these stocks meets or exceeds our benchmarks, our subscribers are immediately notified directly to their in-box.
This is a free service available only to our subscribers. Scroll to the bottom of this page to signup for free stock alerts and visit our site.
During 2009 our alerts have resulted in an average price gain of 80%+.
Disclaimer: Full disclaimer at http://StockEinstein.com/disclaimer.php
IMPORTANT: Never invest in any stock featured in any press release, email or website unless you can afford the loss of your entire investment. Stocks and particularly penny stocks have the possibility for dramatic gains, and also losses. Neither StockEinstein, nor any of its affiliates are registered investment advisors or broker dealers.